Marinus Pharmaceuticals, Inc
MRNS
MRNS was delisted on the 10th of February, 2025.
23 hedge funds and large institutions have $4.98M invested in Marinus Pharmaceuticals, Inc in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
12% less funds holding
Funds holding: 26 → 23 (-3)
55% less capital invested
Capital invested by funds: $11M → $4.98M (-$6.04M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$109K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$30.5K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$29.7K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$18K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$16.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.72M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$208K |
| 3 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$116K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$105K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$46.8K |
MRNS Hedge Fund Activity: Q4 2016 in Review
23 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Marinus Pharmaceuticals, Inc (MRNS) for Q4 2016, worth a combined $4.98M — down 55% from $11M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of MRNS and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was BlackRock Institutional Trust, adding an estimated $109K. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $1.72M sold.
- 23 institutional investors held Marinus Pharmaceuticals, Inc (MRNS) as of Q4 2016, down from 26 in Q3 2016.
- Funds reported $4.98M of Marinus Pharmaceuticals, Inc stock for Q4 2016, down 55% quarter-over-quarter.
- 2 funds opened new Marinus Pharmaceuticals, Inc positions in Q4 2016 and 5 closed out, a net change of -3 holders.
- The largest Marinus Pharmaceuticals, Inc buyer in Q4 2016 was BlackRock Institutional Trust, an estimated $109K added.
- The largest Marinus Pharmaceuticals, Inc seller in Q4 2016 was ArrowMark Colorado Holdings, an estimated $1.72M sold.
Based on aggregated 13F filings for Q4 2016.